MediSpend Acquires Real Life Sciences
January 27, 2025
MediSpend, a Susquehanna Growth Equity‑backed life sciences technology company, has acquired Real Life Sciences (RLS), a provider of advanced anonymization and redaction solutions for clinical trial data. The deal expands MediSpend's Governance, Risk and Compliance (GRC) capabilities—adding RLS Protect SaaS and expert anonymization services to support pharma, biotech and CRO clients with regulatory disclosure and participant privacy.
- Buyers
- MediSpend
- Targets
- Real Life Sciences
- Industry
- Cloud & SaaS
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Susquehanna Growth Equity Makes Majority Growth Investment in MediSpend
May 26, 2021
Cloud & SaaS
Susquehanna Growth Equity (SGE) made a majority growth investment in MediSpend, a Portsmouth, New Hampshire–based provider of SaaS compliance solutions for the life sciences industry. The investment will fund product and client expansion across life sciences; Scott Feldman of SGE will join MediSpend’s board alongside CEO Craig Hauben and existing investors Steve Eaton and Dave Cormack. Financial terms were not disclosed.
-
LLR Partners Invests in RealTime Software Solutions
January 13, 2022
Cloud & SaaS
LLR Partners has made a growth investment in RealTime Software Solutions, a provider of cloud-based clinical research software (CTMS, eRegulatory, eSource, payments and engagement tools). The capital will be used to accelerate growth, product innovation and customer experience, with LLR joining the company's board and Crosstree Capital Partners advising the transaction.
-
MediSpend Acquires MedCompli
May 22, 2024
Software
MediSpend, a Portsmouth, New Hampshire–based commercial compliance technology company, has acquired MedCompli, a life-sciences compliance software and services provider, effective May 17, 2024. The acquisition expands MediSpend’s product portfolio and subject-matter expertise—bringing complementary SaaS and advisory capabilities into its PE-backed platform to better serve life sciences customers globally.
-
RLDatix Acquires Porzio Life Sciences from Porzio, Bromberg & Newman
November 1, 2022
Cloud & SaaS
RLDatix has acquired Porzio Life Sciences, a provider of compliance and risk-management SaaS products for the life sciences industry, from the law firm Porzio, Bromberg & Newman. The acquisition expands RLDatix's governance, risk and compliance (GRC) and life sciences capabilities and will see Porzio Life Sciences' founder join RLDatix as President and GM of its life sciences division.
-
LyfeSci Research & Innovation Acquires Clinically Media
January 12, 2026
Healthcare Services
LyfeSci Research & Innovation, a Chicago-area full-service CRO, has acquired Clinically Media to bring patient recruitment capabilities in-house and expand end-to-end clinical trial execution. Clinically Media — a data-driven patient recruitment agency focused on dermatology, neurology, and psychiatry — will be integrated into LyfeSci's CRO services and operate under the LyfeSci brand to improve protocol feasibility, site selection, and enrollment optimization.
-
LLR Partners Makes Growth Investment in Genesee Scientific
October 19, 2021
Medical Devices
LLR Partners completed a growth investment in Genesee Scientific, a San Diego–based manufacturer and distributor of life-science consumables and laboratory equipment. The partnership will fund expansion of Genesee's product portfolio and scaling of its national footprint; Audax Private Debt provided unitranche financing to support the transaction.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.